Evidence map›Paper›PMID 11884595›Full record

ArticleMolecular and cellular biology2002

Targeted transposition by the V(D)J recombinase.

Gregory S Lee, Matthew B Neiditch, Richard R Sinden, David B Roth

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Different classes of genomic inserts contribute to human antibody diversity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. V(D)J recombination: Born to be wild.Seminars in cancer biology · 2010
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gregory S LeeDepartment of Immunology, Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030, USA.
Matthew B Neiditch
Richard R Sinden
David B Roth
Howard Hughes Medical Institute · USTexas A&M University System · US

Funding

Mechanisms of V(D) J RecombinationR01AI036420 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTH, DAVID B. · 1994 to 2009
$2.6M
NIAID NIH HHS AI-36420NIAID NIH HHS R01 AI036420
6 · The paper itself

Abstract

Cleavage by the V(D)J recombinase at a pair of recombination signal sequences creates two coding ends and two signal ends. The RAG proteins can integrate these signal ends, without sequence specificity, into an unrelated target DNA molecule. Here we demonstrate that such transposition events are greatly stimulated by--and specifically targeted to--hairpins and other distorted DNA structures. The mechanism of target selection by the RAG proteins thus appears to involve recognition of distorted DNA. These data also suggest a novel mechanism for the formation of alternative recombination products termed hybrid joints, in which a signal end is joined to a hairpin coding end. We suggest that hybrid joints may arise by transposition in vivo and propose a new model to account for some recurrent chromosome translocations found in human lymphomas. According to this model, transposition can join antigen receptor loci to partner sites that lack recombination signal sequence elements but bear particular structural features. The RAG proteins are capable of mediating all necessary breakage and joining events on both partner chromosomes; thus, the V(D)J recombinase may be far more culpable for oncogenic translocations than has been suspected.

Indexed as

Gene TargetingAnimalsBase SequenceCHO CellsCricetinaeDNADNA-Binding ProteinsDNA NucleotidyltransferasesDNA, RecombinantDNA TopoisomerasesDNA Transposable ElementsGene RearrangementHomeodomain ProteinsHumansMolecular Sequence DataNuclear ProteinsDNADNA-Binding ProteinsDNA NucleotidyltransferasesDNA, RecombinantDNA TopoisomerasesDNA Transposable ElementsHomeodomain ProteinsNuclear ProteinsRAG-1 proteinRAG2 protein, humanVDJ RecombinasesV(D)J recombination activating protein 2Non-programmatic

Identifiers

PMID11884595
PMCPMC133684
OpenAlexW2167192396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.